This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2006 Mar 31;311(5769):1875-6.

doi: 10.1126/science.1126030.

Immunology. An antibody paradox, resolved

Martin Prlic¹, Michael J Bevan

Affiliations

PMID: 16574856
DOI: 10.1126/science.1126030

Comment

Immunology. An antibody paradox, resolved

Martin Prlic et al. Science. 2006.

. 2006 Mar 31;311(5769):1875-6.

doi: 10.1126/science.1126030.

Authors

Martin Prlic¹, Michael J Bevan

Affiliation

¹ Department of Immunology and the Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195-7370, USA. mprlic@u.washington.edu

PMID: 16574856
DOI: 10.1126/science.1126030

No abstract available

PubMed Disclaimer

Comment on

Selective stimulation of T cell subsets with antibody-cytokine immune complexes.
Boyman O, Kovar M, Rubinstein MP, Surh CD, Sprent J. Boyman O, et al. Science. 2006 Mar 31;311(5769):1924-7. doi: 10.1126/science.1122927. Epub 2006 Feb 16. Science. 2006. PMID: 16484453

Similar articles

Selective stimulation of T cell subsets with antibody-cytokine immune complexes.
Boyman O, Kovar M, Rubinstein MP, Surh CD, Sprent J. Boyman O, et al. Science. 2006 Mar 31;311(5769):1924-7. doi: 10.1126/science.1122927. Epub 2006 Feb 16. Science. 2006. PMID: 16484453
Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimera.
Votavova P, Tomala J, Kovar M. Votavova P, et al. Immunol Lett. 2014 May-Jun;159(1-2):1-10. doi: 10.1016/j.imlet.2014.01.017. Epub 2014 Feb 7. Immunol Lett. 2014. PMID: 24512738 Review.
Efficient augmentation of a long-lasting immune responses in HIV-1 gag DNA vaccination by IL-15 plasmid boosting.
Li W, Li S, Hu Y, Tang B, Cui L, He W. Li W, et al. Vaccine. 2008 Jun 19;26(26):3282-90. doi: 10.1016/j.vaccine.2008.03.081. Epub 2008 Apr 18. Vaccine. 2008. PMID: 18472194
Teaching tired T cells to fight HIV: time to test IL-15 for immunotherapy?
Mastroianni CM, d'Ettorre G, Forcina G, Vullo V. Mastroianni CM, et al. Trends Immunol. 2004 Mar;25(3):121-5. doi: 10.1016/j.it.2004.01.002. Trends Immunol. 2004. PMID: 15036038 Review. No abstract available.
Are CD8+CD122+ cells regulatory T cells or memory T cells?
Suzuki H, Shi Z, Okuno Y, Isobe K. Suzuki H, et al. Hum Immunol. 2008 Nov;69(11):751-4. doi: 10.1016/j.humimm.2008.08.285. Epub 2008 Sep 24. Hum Immunol. 2008. PMID: 18817826 Review.

See all similar articles

Cited by

IL-2 complex treatment amplifies CD8⁺ T cell mediated immunity following herpes simplex virus-1 infection.
Rajasagi NK, Rouse BT. Rajasagi NK, et al. Microbes Infect. 2016 Dec;18(12):735-746. doi: 10.1016/j.micinf.2016.10.010. Epub 2016 Nov 17. Microbes Infect. 2016. PMID: 27866863 Free PMC article.
Rapid generation of a functional NK-cell compartment.
Prlic M, Kamimura D, Bevan MJ. Prlic M, et al. Blood. 2007 Sep 15;110(6):2024-6. doi: 10.1182/blood-2007-04-086108. Epub 2007 Jun 6. Blood. 2007. PMID: 17554057 Free PMC article.
Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation.
Hao J, Campagnolo D, Liu R, Piao W, Shi S, Hu B, Xiang R, Zhou Q, Vollmer T, Van Kaer L, La Cava A, Shi FD. Hao J, et al. Ann Neurol. 2011 Apr;69(4):721-34. doi: 10.1002/ana.22339. Epub 2011 Mar 18. Ann Neurol. 2011. PMID: 21425186 Free PMC article.
CIMT 2013: advancing targeted therapies--report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14-16 2013, Mainz, Germany.
Diken M, Attig S, Grunwitz C, Kranz L, Simon P, van de Roemer N, Vascotto F, Kreiter S. Diken M, et al. Hum Vaccin Immunother. 2013 Sep;9(9):2025-32. doi: 10.4161/hv.25768. Epub 2013 Jul 22. Hum Vaccin Immunother. 2013. PMID: 23877042 Free PMC article.
Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV.
Zhang R, Zhang S, Li M, Chen C, Yao Q. Zhang R, et al. Vaccine. 2010 Jul 12;28(31):5114-27. doi: 10.1016/j.vaccine.2010.03.079. Epub 2010 May 14. Vaccine. 2010. PMID: 20471443 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database